PG vs XOM: Which Is the Better Buy?

Side-by-side comparison of The Procter & Gamble Company and Exxon Mobil Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-19.
The Procter & Gamble Company Β· Consumer Defensive
$147.04
+14.4% upside to fair value
Med Conviction Grade B+ High Quality
VS
Exxon Mobil Corporation Β· Energy
$163.18
+10.3% upside to fair value
Med Conviction Grade B High Quality
QuantHub Verdict
PG has more upside to fair value (+14.4%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric PG XOM
Current Price $147.04 $163.18
Fair Value Estimate $168.19 $179.98
Upside to Fair Value +14.4% +10.3%
Market Cap $349.5B $676.3B
Forward P/E β€” β€”
EV / EBITDA 17.6x 9.9x
Price / Sales 4.0x 1.9x
Price / FCF 22.4x 22.3x
Revenue Growth YoY +1.5% +44.1%
Gross Margin 50.2% 25.1%
Operating Margin 22.7% 10.7%
Return on Equity 29.8% 12.7%
Dividend Yield 2.92% 2.52%
FCF Yield 4.47% 4.49%
Analyst Consensus Buy Hold
Investment Thesis
PG β€” The Procter & Gamble Company
Procter & Gamble is a global consumer-staples leader selling daily-use products across beauty, grooming, health care, fabric and home care, and baby, feminine and family care in about 180 countries. Business quality is high because its brands, consumer insight, R&D, marketing scale and global distribution underpin leading category positions, including over 60% in blades and razors and over 35% in…
XOM β€” Exxon Mobil Corporation
Exxon Mobil is the largest integrated oil and gas major in the United States, operating across Upstream exploration and production, Downstream refining and fuels marketing, and Chemical manufacturing, with roughly 57,900 employees and a portfolio that spans conventional crude and natural gas, LNG, petrochemicals, and early-stage carbon capture, hydrogen, and biofuels ventures. The business qualit…
Accumulation Zones
Metric PG XOM
Zone Low $126.14 $134.98
Zone High $142.96 $152.98
In Buy Zone? No No
← PG Research    XOM Research β†’    All Research